Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs ActivatorsView this Special Issue
The Role of Nrf2 in Cardiovascular Function and Disease
Free radicals, reactive oxygen/nitrogen species (ROS/RNS), hydrogen sulphide, and hydrogen peroxide play an important role in both intracellular and intercellular signaling; however, their production and quenching need to be closely regulated to prevent cellular damage. An imbalance, due to exogenous sources of free radicals and chronic upregulation of endogenous production, contributes to many pathological conditions including cardiovascular disease and also more general processes involved in aging. Nuclear factor erythroid 2-like 2 (NFE2L2; commonly known as Nrf2) is a transcription factor that plays a major role in the dynamic regulation of a network of antioxidant and cytoprotective genes, through binding to and activating expression of promoters containing the antioxidant response element (ARE). Nrf2 activity is regulated by many mechanisms, suggesting that tight control is necessary for normal cell function and both hypoactivation and hyperactivation of Nrf2 are indicated in playing a role in different aspects of cardiovascular disease. Targeted activation of Nrf2 or downstream genes may prove to be a useful avenue in developing therapeutics to reduce the impact of cardiovascular disease. We will review the current status of Nrf2 and related signaling in cardiovascular disease and its relevance to current and potential treatment strategies.
The vascular endothelium modulates vascular structure, thrombolysis, vasoconstriction, and vasodilation and maintains internal homeostasis through synthesizing and releasing several active biomolecules . A loss of function of the endothelium represents a key risk factor for cardiovascular disease (CVD) and initiates the development of atherosclerosis . Endothelial dysfunction is associated with functional changes that diminish nitric oxide (NO) bioavailability and consequently leads to CVD . Sustained failure to counteract the excessive production of reactive oxygen species (ROS) and dysregulation of the antioxidant defence system in the endothelium elicits cellular damage and dysfunction . However, the original concept that all free radicals are damaging disease-causing entities have, over recent years, been replaced by an understanding of the important signaling role they play within and between cells. The production and control of free radicals need to be tightly regulated to prevent cytotoxicity, and the imbalance, caused by exogenous sources of free radicals with chronic upregulation and endogenous production, contributes to many pathological conditions and also to more general processes involved in aging [3–5]. There are multiple cellular defence strategies to prevent free radical toxicity, which are dynamically regulated to protect from oxidative insults and preserve cell function . Nuclear factor erythroid 2-like 2 (NFE2L2; commonly known as Nrf2 ) has been identified as a major regulator of the oxidant/antioxidant balance.
The Nrf2 was first discovered in 1994 by Moi et al. during studies on regulation of the β-globin gene . It was subsequently identified to be profoundly involved in the regulation of oxidant and antioxidant gene expression, through binding to the antioxidant response element (ARE) [8, 9]. Nrf2/ARE signaling is highly conserved in all species and controls a wide panel of genes that include cytoprotective and detoxifying phase II enzymes . Nrf2 coordinates the cellular response to oxidative insults, preventing damage to cellular components sensitive to redox changes (i.e., proteins, lipids, and DNA).
2. Regulation of Nrf2 Activity
Nrf2 activity is highly regulated, suggesting that either hypoactivation or hyperactivation of Nrf2 may be detrimental to the cell, for example, unrestricted Nrf2 activity, elicited by knockout of Kelch-like ECH-associated protein 1 (KEAP1) in the mouse, results in postnatal lethality , while Nrf2 knockouts are viable but hypersensitive to oxidative stressors. The regulation of Nrf2 has been extensively reviewed elsewhere [12–14] but is briefly summarized here and in Figure 1 and Table 1. Nrf2-regulated gene expression is primarily controlled by KEAP1. In a situation without oxidative stimuli, Nrf2 is mostly sequestered in the cytosol through binding to the Kelch domain of KEAP1 . KEAP1 acts as an adapter molecule for CUL-E3 ligase and mediates the ubiquitination and degradation of Nrf2 protein. Exposure of oxidative/electrophilic stress causes a modification of the cysteine groups on KEAP1 (particularly C151), relaxing the structure of KEAP1 causing dissociation of KEAP1 from CUL-E3 ligase [16–18]. It is unclear if Nrf2 protein dissociates from KEAP1 or if modification of C151 simply blocks further processing of Nrf2 . De novo synthesized Nrf2, or protein released from KEAP1, is then free to translocate to the nucleus. In addition, p21, p62, and the tumor suppressor WTX also potentiate Nrf2 activation through sequestration of KEAP1 or binding to Nrf2 to prevent association with KEAP1 [19–21]. Upon entry into the nucleus, Nrf2 heterodimerizes with a number of transcription factors, including small Maf proteins (allowing formation of full basic zipper, summarized in Figure 1 and Table 1), and binds to the ARE (core sequence RTGACnnnGCA) to induce gene transcription [22, 23].
Dissociation of KEAP1 from the CUL-E3 ligase complex can be induced by a large range of compounds, including oxidized phospholipids , nitric oxide (NO), zinc, alkenals , and cigarette smoke, or fresh aqueous extracts of cigarette smoke [26–28]. However, not all forms of ROS appear to be able to modify KEAP-1/Nrf2 interactions, with data suggesting this is both cell type and context specific. Of particular relevance to CVD, laminar shear stress causes the activation of Nrf2 in endothelial cells , through lipid peroxide and COX2-derived 15-deoxy-12,14-prostaglandin J2 (15d-PGJ2) intermediates, enhanced by phosphoinositol 3-kinase/Akt signaling, but is surprisingly independent of endothelial nitric oxide synthase (eNOS) activity [30–33]. In addition, laminar shear stress increases the nuclear localization of Nrf2 via a KLF2-dependent mechanism . Finally, tumor necrosis factor alpha (TNF-α) increases the activation of Nrf2 in human endothelial cells  and monocytes . A number of naturally occurring compounds have been shown to release Nrf2 from KEAP1 , for example, sulforaphane , sulfuretin , 2-trifluoromethyl-2-methoxychalone , and isoliquiritigenin , suggesting that dietary modulation of ARE-dependent gene expression could play a potential role in modulating disease.
3. Additional Regulatory Systems
In addition to KEAP1-mediated sequestration and degradation of Nrf2 within the cytoplasm, there are a number of additional layers of regulation on Nrf2-dependent gene expression. Degradation of Nrf2 can also be induced by β-TrCP–Skp1–Cul1–Rbx1 E3 ubiquitin ligase complex [41, 42], triggered by phosphorylation of Nrf2 within the Neh2 domain. Subsequently, the E3 ligase complex ubiquitinates Nrf2 and causes its destruction by the proteasome. Mitra et al. also observed that the inhibition of P38 mitogen-activated protein kinase (MAPK) highly decreased Nrf2 nuclear translocation, with a corresponding reduction of Nrf2-dependent gene expression . While the majority of KEAP1 is normally present in the cytoplasm, 10–15% has localized to the nucleus ; prothymosin-alpha (ProTα) binds KEAP1, shuttling it into the nucleus, where it can bind Nrf2 and promote its degradation . Within the nucleus, B-zip proteins BACH1 and BACH2 can form dimers with Maf proteins through their BTB domain and compete for binding to the ARE, preventing Nrf2 binding and activation of transcription [46–48]. BACH1 is universally expressed, while BACH2 expression is predominantly limited to monocytes and in neural cells. Phosphorylation of BACH1 on Y486 provokes nuclear export of BACH1 increasing Nrf2-dependent gene expression [49, 50]. Nuclear export of Nrf2 is controlled through a GSK-3β-controlled phosphorylation cascade. GSK-3β phosphorylates Src family kinases (Src, YES, and Fyn), in turn phosphorylating Nrf2 on Y568 triggering nuclear export and degradation [51–53].
4. Nrf2 and Mitochondrial Dynamics in Cardiovascular Disease
Cardiovascular disease is the main cause of death worldwide , and it covers a wide array of disorders. The most common causes of CVD morbidity and mortality are stroke, ischemic heart disease (IHD), and congestive heart failure (CHF). Several risk profiles are involved in CVD where ROS is a central mediator and a common denominator, upregulated by multiple risk factors such as diabetes, inflammation, and smoking [79–81]. ROS can cause EC apoptosis and activate nuclear factor kappa-B (NF-κB), increasing adhesion molecules and cytokines that enhance monocyte adhesion [82, 83]. Oxidative stress is involved in mitochondrial dysfunction, which is related to bioenergetic defects and an alteration in mitochondrial dynamics. This provokes transcription impairment and cell damage. Blockage of the mitochondrial electron transfer in complex III in diabetes leads to the release of electrons which reduce molecular oxygen to superoxide (O2•) and increases intracellular ROS production . Furthermore, ROS can activate membrane oxidases with a subsequent increase in the levels of asymmetric dimethylarginine that competes for the L-arginine transporters and active sites on eNOS . Nrf2 modulates the activity of the mitochondrial respiration chain , with pharmacological activation of Nrf2 protecting against toxicity and maintaining mitochondrial homeostasis possibly via ablation of Akt2 signaling . Liu and colleagues discovered acrolein, a component of cigarette combustion, inactivated the KEAP1/Nrf2 pathway, and decreased mitochondrial membrane potential , while Zou et al. demonstrated the ability of Nrf2 to prevent mitochondrial dysfunction, using hydroxytyrosol to activate Nrf2 .
5. Nrf2 in Endothelial Dysfunction
The vascular endothelium modulates vascular homeostasis through synthesizing and releasing several active biomolecules . A loss of endothelium integrity represents a key risk factor for CVD, initiating atherosclerosis  and is associated with functional changes that diminish NO bioavailability and, consequently, lead to CVD . Hypoxia, flow disturbances, and oxidative stress are important contributors to endothelial dysfunction . Failure to counteract excessive production of ROS and modulation of the anti-oxidant defence system in the endothelium elicits cellular damage and dysfunction .
Normal vascular endothelial physiology is dependent on NO production via coupling of the eNOS heme group with L-arginine using tetrahydrobiopterin (BH4) as a cofactor . Excess ROS induce the conversion of BH4 to 7,8-dihydrobiopterin (BH2) with subsequent eNOS uncoupling and synthesis of O2• instead of NO  (Figure 2). O2• can react with NO to produce the versatile oxidant peroxynitrite (ONOO−) . The upregulation of iNOS and uncoupling of eNOS under hyperglycemic conditions are now well established [93, 94]. L-arginine is also a substrate for arginase  which is upregulated in the endothelium of coronary arterioles in hypertension and contributes to the impaired NO-mediated dilation . In addition, ONOO− and hydrogen peroxide (H2O2) were reported to increase the activity/expression of arginase in endothelial cells , thus exacerbating the defects in myogenic tone. Therefore, ROS can trigger eNOS uncoupling through depletion of the substrate L-arginine. This notion has been supported by the study of Romero et al.  where increased arginase activity elicited L-arginine depletion and contributed to endothelial dysfunction in diabetes. ONOO− can also activate NADPH oxidases and influences further generation of ROS . Additionally, blockage of the mitochondrial electron transfer in complex III in diabetes leads to the release of electrons, which reduce molecular oxygen to O2• and increase intracellular ROS production . Furthermore, ROS can activate membrane oxidases with a subsequent increase in the levels of asymmetric dimethylarginine that competes for the L-arginine transporters and active sites on eNOS .
Nrf2 in the endothelium can be activated via increased ROS production and PI3K-Akt signaling triggered by laminar shear stress . In human arterial endothelial cells, Nrf2 activation resulted in increased intracellular HMOX1, GPx, GSH, GCLM, SRXN1, NQO1, PAR4, and OSGIN1 [27, 28, 100]. Adenoviral overexpression of Nrf2 in endothelial cells infected showed decreased expression of TNF-α, IL-1β, MCP1, and VCAM1, pointing to the anti-inflammatory potential of Nrf2 [28, 101]. When shear stress is disturbed at bifurcations, curved sections of arteries or distal to regions of stenosis, NO bioavailability decreases, O2• generation increases , and Nrf2-activated genes are diminished, causing the endothelium to become predisposed to atherogenesis . Our recent studies have demonstrated that free fatty acid- (FFA-) induced excessive ROS production diminished both the gene and protein expression of Nrf2, NQO1, and HO-1 in endothelial cells . In addition, upregulation of Nrf2/ARE/HMOX1 signaling protected the human endothelial cells against TNF-α activation . It could be that mitochondrial ROS may trigger a protective response via Nrf2 activation in endothelial cells. The study of Lo and Hannink  suggested that Nrf2–KEAP1 complex binds to the mitochondria through interaction with mitochondrial outer membrane protein PGAM5 and directly senses mitochondrial ROS production.
Another possibility through which Nrf2 can protect the endothelium against the cytotoxic ROS involves regulating the catalytic subunit of GCLC which reduces GSH biosynthesis . In this context, impaired Nrf2–KEAP1–GCLC has been demonstrated in high glucose-induced retinal endothelial cells from diabetic donors . In the human brain microvascular endothelial cells (HBVEC), GSH conferred protection against FFA-induced oxidative stress and apoptosis by activating the Akt pathway . Human umbilical vein endothelial cells (HUVECs), human coronary artery endothelial cells (HCAECs), and endothelial progenitor cells exposed to cytotoxic ROS showed apoptosis and cell death accompanied by diminished nuclear localization and transcriptional activity of Nrf2 . These findings highlight the crucial role of Nrf2 activation in protecting endothelial cells against oxidative stress-induced dysfunction.
6. Nrf2 in Atherosclerosis
Atherosclerosis is a focal inflammatory disease of the arterial system involving a number of different cell types. The focal nature of atherosclerosis highlights the involvement of local haemodynamics factors acting on the endothelium in the initiation and progression of atherosclerosis, which develops in regions that experience disturbed flow at bifurcations and curved sections of artery [110–113]. Straight sections of artery that experience normal laminar blood flow are relatively spared from disease through a coordinated modulation of gene expression, predominantly controlled by the transcription factors KLF2 and KLF4 and activation of Nrf2 [29, 32, 114–116]. By contrast, endothelial cells exposed to disturbed flow adopt a phenotype that amplifies endothelial dysfunction and increases permeability. While ROS are essential signaling molecules regulating vascular homeostasis, excessive ROS, elevated by many of the risk factors associated with the development of atherosclerosis, promote endothelial dysfunction and decrease NO availability. Thus, Nrf2-regulated antioxidant gene expression may play an atheroprotective role in endothelial cells.
Consistent with this hypothesis, the Nrf2-regulated gene, heme oxygenase 1 (HMOX1), demonstrates significant cytoprotective and anti-inflammatory effects that result in a reduction of atherosclerosis in mouse models , possibly through production of low levels of carbon monoxide. Hypercholesterolemic mice, deficient in both HMOX1 and ApoE (HMOX1−/−/ApoE−/−), demonstrated enhanced development of atherosclerosis compared to ApoE−/− single knockout mice . HMOX1 expression in macrophages plays a protective role in atherosclerosis  with macrophages from HMOX1−/− mice displaying increased ROS generation, production of inflammatory cytokines, and increased foam cell formation when treated with oxLDL, attributable in part to increased expression of scavenger receptor A (SR-A). Smooth muscle cells from HMOX1−/− mice not only displayed increase neointimal formation but also enhanced cell death potentially due to greater susceptibility to oxidant stress . Pharmacological modulation of HMOX1 expression also demonstrates a protective role of HMOX1 in atherogenesis [120, 121]. In addition to the anti-inflammatory effects of carbon monoxide, hydrogen sulphide also elicits an anti-inflammatory antiatherogenic effect . Hydrogen sulfide activates the release of Nrf2 from KEAP1, increasing Nrf2-dependent gene expression .
Despite the antioxidant function of Nrf2 and the antiatherogenic function of the key Nrf2 target gene HMOX1, the global knockout of Nrf2 (Nrf2−/−) developed less rather than more atherosclerosis [123, 124]. Barajas et al. attributed this to an effect of Nrf2 in lipid metabolism, lowering plasma cholesterol and reducing foam cell formation , while Sussan et al. did not find a difference in serum cholesterol but attributed the effect to a reduction in scavenger receptor CD36 reducing foam cell formation . The role of Nrf2 in NLRP3 inflammasome induction by cholesterol crystals within the atherosclerotic plaque may also be a contributing factor that explains the counterintuitive net detrimental effect of Nrf2 in hypercholesterolemic mouse models of atherosclerosis . It might also explain why the expression of the Nrf2-regulated gene HMOX1 is highest in human plaques with the highest markers of plaque instability .
7. Nrf2 in Vascular Calcification
The presence of vascular calcification is often detected in atherosclerotic plaques and in patients with end-stage renal disease. Both of these pathologies have been targeted for prevention using pharmacological and genetic approaches by modulation of Nrf2 antioxidant pathways. For example, studies in vitro using rodent vascular smooth muscle cells show that dimethyfumarate or resveratrol could attenuate the deposition of a mineralised matrix and suggest protection against oxidative stress-induced mitochondrial damage, via activation of Nrf2 and SIRT1 signaling and downregulation of osteogenic transcription factors [126, 127]. In contrast, glucose-induced oxidative stress enhances the osteogenic differentiation and mineralisation of human embryonic stem (ES) cells, by the upregulation of runt-related transcription factor 2 (Runx2), Nrf2, and HMOX1, which was inhibited by Nrf2 knockdown  highlighting a context-specific regulation of the calcification process. Given the links between Nrf2 and bone homeostasis, it is not surprising to have an association between Nrf2 signaling and vascular calcification. Whether these initial in vitro studies can translate into the in vivo situation needs further study.
8. Nrf2 in Hypertension
Angiotensin II and associated renin-angiotensin system (RAS) are involved in the regulation of blood pressure, vasoconstriction, sodium intake, and potassium excretion . Inappropriate activation of the RAS is the main cause of profound hypertension and cardiovascular morbidity. Angiotensin II increases the expression of NADPH oxidase and the generation of ROS potentially mediating some of the effects in renin-angiotensin-induced hypertension [130, 131]. It has been suggested that hypertension could be one of the causes of Nrf2 misregulation and not vice versa  through enhanced oxidative stress and vascular dysfunction in a hypertensive rat model . This would suggest that the Nrf2 anti-oxidant defence system is insufficient to counteract the effects of oxidative stress, possibly due to elevated levels of Nrf2 repressors in hypertensive animals. Research is now moving from the adaptive and protective changes in the Nrf2 antioxidant response to focusing on the alternative mechanisms intrinsic to upstream and downstream molecules associated with a defective Nrf2 signaling system. Enhancing Nrf2 activity may have a therapeutic potential for a meliorating hypertension.
9. Nrf2 in Diabetic Cardiomyopathy
The heart is particularly vulnerable to oxidative damage compared to other organs, due to its low basal levels of antioxidant defences . Diabetic cardiomyopathy (DCM) and other cardiovascular complications account for more than 80% of deaths among patients with diabetes . DCM is characterized by impaired diastolic function, hypertrophy, apoptosis, and fibrosis of cardiomyocytes  and involves several mechanisms and pathogenic factors, with oxidative stress thought to be the common link [137–140]. Hyperglycemia generates excess ROS/RNS from activation of NADPH oxidases, PKC, leakage of the mitochondrial electron transport chain, eNOS uncoupling, AGE/RAGE signaling, xanthine oxidase, and 12/15-lipoxygenase (LOX) , impairing antioxidant defences in the diabetic heart [138, 140] (Figure 3).
Studies have established the importance of Nrf2/ARE signaling in the prevention of diabetic complications [142–144] and oxidative stress-induced cardiomyocyte injury [145, 146]. Significantly reduced Nrf2 expression has been observed in the left ventricle of diabetic patient heart by histological analysis , which has also been observed in a diabetic mouse model after 5 months . These findings suggest adaptive overexpression of Nrf2 to combat early oxidative damage in diabetes, which is overcome by sustained ROS production and exhaustion of the antioxidant defences . This concept is supported by our findings in palmitate-treated endothelial cells, where reduced Nrf2 expression and antioxidant defences are observed with surplus ROS .
Furthermore, it has been demonstrated that Nrf2 and its downstream target genes are downregulated in cardiomyocytes from diabetic (db/db) mice [146, 147], which may occur via extracellular signal-regulated protein kinase (ERK) 1/2 activity [149, 150]. Isoproterenol-stimulated contraction of primary cardiomyocytes from adult diabetic mice was also shown to be dependent on Nrf2 . Hence, hyperglycemia-induced loss of Nrf2 function exacerbates oxidative stress and leads to severe myocardial damage . Nrf2 knockout mice exhibit structural and functional abnormalities under conditions of pathological stress , and cardiomyocytes from Nrf2-knockout mice showed significantly increased apoptosis following incubation with high glucose . These findings highlight the importance of the Nrf2 protective mechanisms, and thus, novel therapeutics to enhance Nrf2 could be beneficial in this scenario. The proteasome inhibitor MG-132, which increases Nrf2 signaling, was reported to decrease left ventricle hypertrophy by reducing inflammation and lowering the risk of cardiomyopathy . In addition, in a mouse model of type I diabetes mellitus, Nrf2 activation by sulforaphane reduced heart weight and decreased diabetes-induced atrial natriuretic peptide (ANP) expression, thought to be related to induction of DCM . Therefore, enhancing endogenous Nrf2 and subsequent antioxidant pathways in the heart is a potential strategy to prevent DCM [138, 155].
10. Nrf2 in the Aging Heart
Aging, a progressive decline of cellular functions, is related to the loss of homeostasis via a combination of epigenetic alterations and genetically programmed processes resulting in death [156, 157]. Heart capacity declines with age, with a concomitant increased CVD risk . Herman’s free radical theory proposes that the accumulation of damaged biomolecules by ROS/RNS plays a central role in aging [159–161]. In turn, this leads to activation of NF-κB , eliciting an inflammatory response via TNF-α, IL-6, and C reactive protein (CRP), reported to be associated with aging , and further stimulation of ROS production through activation of NADPH oxidase [164, 165] and NF-κB . In support of this, elderly patients demonstrate an impaired endothelial-dependent dilation, associated with excess ROS, activated NADPH oxidase, and increased NF-κB .
Elevated ROS also increase the rate of apoptosis and necrosis in cardiomyocytes , resulting in functional and phenotypic changes, including decreased remodelling , cardiac hypertrophy , and increased systolic pressure [171, 172]. NADPH oxidase-2, its activator RAC1, and several profibrotic factors are elevated in hypertrophic hearts in aged rats , pointing to the important role of NADPH oxidase in aging-associated cardiomyocyte remodelling. Ischemia and reperfusion are characterized by increased accumulation of intracellular Ca2+, altered substrate utilization, and elevated ROS production in the heart , which can damage ionic pumps and induce mitochondrial dysfunction via lipid peroxidation . This damage can lead to necrotic cell death  and is exacerbated with aging [160, 176], as shown in mitochondria from aged rats .
Diminished activity of Nrf2 resulting in oxidative stress, apoptosis, and/or necrosis in the myocardium has been reported [178–180], thus predisposing the heart to disease . Studies in mouse models have supported the notion that Nrf2 is involved in counteracting aging-associated cardiac effects via ARE signaling and expression of antioxidant enzymes. Bailey-Downs et al.  reported increased sensitivity of blood vessels to stress-induced damage along with impaired activity of Nrf2 in insulin-like growth factor 1 (Igf1) knockout mice, promoting an aging phenotype. Nrf2-knockout mice showed exaggerated cardiac hypertrophy, heart failure, increased mortality , and oxidative stress . Aged rhesus macaques have shown increased ROS and decreased nuclear translocation of Nrf2 and protein expression of NQO1 and HO-1 in their carotid arteries . Vascular smooth muscle cells (VSMCs) derived from old monkeys have exhibited diminished Nrf2 activation following incubation with high glucose as compared with those derived from younger monkeys . Additionally, El Assar et al.  have reported a decreased expression of Nrf2-regulated antioxidants in aged vessels.
These data demonstrate clearly that decreasing levels of Nrf2 are age-dependent but may be reversed by exercising. Muthusamy et al.  demonstrated an increased nuclear translocation of Nrf2 in the hearts of mice following acute exercise training. They attributed their findings to the induction of an exercise-induced mild oxidative state. Endurance exercise training was reported to promote Nrf2 signaling and enhance antioxidant capacity in the hearts of 6-month-old mice , which might offset the reduced signaling observed in aged mice and men [171, 185–187].
11. Role of Nrf2 Activation in the Treatment of CVD
The role of activators of Nrf2 in attenuating oxidative stress-mediated cardiovascular disorders has been identified. In Table 2, we present a summary of the recently studied activators of Nrf2 and their beneficial effects in CVD.
The Nrf2 antioxidant system plays a significant role in cellular defence against free radical damage, while insufficiency of Nrf2-dependent gene expression is clearly implicated in multiple aspects and stages of CVD. Enhancing Nrf2 activity may be beneficial in diabetic cardiomyopathy, mitochondrial dysfunction, and reducing the effects of aging in the heart; however, the potential exacerbation of atherosclerosis by Nrf2-mediated inflammasome activation in plaque macrophages, along with the lethality of KEAP1 knockout mice, raises a cautionary note to pharmacological activation of Nrf2 as a therapeutic strategy. Selective upregulation of Nrf2 target genes such as HMOX1 may provide a more amenable therapeutic strategy. Modest activation of Nrf2 by dietary factors, such as sulforaphane, found in brassicas like broccoli, may highlight mild activation of Nrf2 as part of the protective role played in eating a healthy balanced diet, which may be sufficient to maximise the therapeutic benefit offered through the control of this gene expression network.
Conflicts of Interest
The authors have no conflicts of interest to declare.
Sandro Satta and Ayman M. Mahmoud contributed equally to this work.
P. Moi, K. Chan, I. Asunis, A. Cao, and Y. W. Kan, “Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region,” Proceedings of the National Academy of Sciences, vol. 91, no. 21, pp. 9926–9930, 1994.View at: Google Scholar
R. Venugopal and A. K. Jaiswal, “Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene,” Proceedings of the National Academy of Sciences, vol. 93, no. 25, pp. 14960–14965, 1996.View at: Google Scholar
K. Itoh, N. Wakabayashi, Y. Katoh et al., “Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain,” Genes & Development, vol. 13, no. 1, pp. 76–86, 1999.View at: Google Scholar
A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al., “Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants,” Proceedings of the National Academy of Sciences, vol. 99, no. 18, pp. 11908–11913, 2002.View at: Publisher Site | Google Scholar
G. Rachakonda, Y. Xiong, K. R. Sekhar, S. L. Stamer, D. C. Liebler, and M. L. Freeman, “Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3,” Chemical Research in Toxicology, vol. 21, no. 3, pp. 705–710, 2008.View at: Publisher Site | Google Scholar
A. L. Eggler, G. Liu, J. M. Pezzuto, R. B. van Breemen, and A. D. Mesecar, “Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 29, pp. 10070–10075, 2005.View at: Publisher Site | Google Scholar
W. W. Wasserman and W. E. Fahl, “Functional antioxidant responsive elements,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 10, pp. 5361–5366, 1997.View at: Google Scholar
M. McMahon, D. J. Lamont, K. A. Beattie, and J. D. Hayes, “Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals,” Proceedings of the National Academy of Sciences, vol. 107, no. 44, pp. 18838–18843, 2010.View at: Publisher Site | Google Scholar
J. E. Teasdale, A. C. Newby, N. J. Timpson, M. R. Munafo, and S. J. White, “Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture,” Drug and Alcohol Dependence, vol. 163, pp. 256–260, 2016.View at: Publisher Site | Google Scholar
J. E. Teasdale, G. G. J. Hazell, A. M. G. Peachey et al., “Cigarette smoke extract profoundly suppresses TNFα-mediated proinflammatory gene expression through upregulation of ATF3 in human coronary artery endothelial cells,” Scientific Reports, vol. 7, article 39945, 2017.View at: Publisher Site | Google Scholar
G. Dai, S. Vaughn, Y. Zhang, E. T. Wang, G. Garcia-Cardena, and M. A. Gimbrone, “Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2,” Circulation Research, vol. 101, no. 7, pp. 723–733, 2007.View at: Publisher Site | Google Scholar
Y.-S. Keum, S. Yu, P. P.-J. Chang et al., “Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element–mediated heme oxygenase-1 in human hepatoma HepG2 cells,” Cancer Research, vol. 66, no. 17, pp. 8804–8813, 2006.View at: Publisher Site | Google Scholar
D.-S. Lee, K.-S. Kim, W. Ko et al., “The cytoprotective effect of sulfuretin against tert-butyl hydroperoxide-induced hepatotoxicity through Nrf2/ARE and JNK/ERK MAPK-mediated heme oxygenase-1 expression,” International Journal of Molecular Sciences, vol. 15, no. 5, pp. 8863–8877, 2014.View at: Publisher Site | Google Scholar
M. Cuendet, C. P. Oteham, R. C. Moon, and J. M. Pezzuto, “Quinone reductase induction as a biomarker for cancer chemoprevention,” Journal of Natural Products, vol. 69, no. 3, pp. 460–463, 2006.View at: Google Scholar
P. Rada, A. I. Rojo, S. Chowdhry, M. McMahon, J. D. Hayes, and A. Cuadrado, “SCF/β-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner,” Molecular and Cellular Biology, vol. 31, no. 6, pp. 1121–1133, 2011.View at: Publisher Site | Google Scholar
M. McMahon, K. Itoh, M. Yamamoto, and J. D. Hayes, “Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression,” Journal of Biological Chemistry, vol. 278, no. 24, pp. 21592–21600, 2003.View at: Publisher Site | Google Scholar
K. Igarashi, H. Hoshino, A. Muto et al., “Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for β-globin locus control region complex,” Journal of Biological Chemistry, vol. 273, no. 19, pp. 11783–11790, 1998.View at: Google Scholar
H. Hoshino, A. Kobayashi, M. Yoshida et al., “Oxidative stress abolishes leptomycin B-sensitive nuclear export of transcription repressor Bach2 that counteracts activation of Maf recognition element,” Journal of Biological Chemistry, vol. 275, no. 20, pp. 15370–15376, 2000.View at: Google Scholar
S. Dhakshinamoorthy, A. K. Jain, D. A. Bloom, and A. K. Jaiswal, “Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants,” Journal of Biological Chemistry, vol. 280, no. 17, pp. 16891–16900, 2005.View at: Publisher Site | Google Scholar
J. W. Kaspar and A. K. Jaiswal, “Antioxidant-induced phosphorylation of tyrosine 486 leads to rapid nuclear export of Bach1 that allows Nrf2 to bind to the antioxidant response element and activate defensive gene expression,” Journal of Biological Chemistry, vol. 285, no. 1, pp. 153–162, 2010.View at: Publisher Site | Google Scholar
A. K. Jain and A. K. Jaiswal, “Phosphorylation of tyrosine 568 controls nuclear export of Nrf2,” Journal of Biological Chemistry, vol. 281, no. 17, pp. 12132–12142, 2006.View at: Google Scholar
S. K. Niture, A. K. Jain, P. M. Shelton, and A. K. Jaiswal, “Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression,” Journal of Biological Chemistry, vol. 286, no. 33, pp. 28821–28832, 2011.View at: Publisher Site | Google Scholar
K. Itoh, T. Chiba, S. Takahashi et al., “An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements,” Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 313–322, 1997.View at: Google Scholar
K. I. Tong, Y. Katoh, H. Kusunoki, K. Itoh, T. Tanaka, and M. Yamamoto, “Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 2887–2900, 2006.View at: Publisher Site | Google Scholar
Y. Katoh, K. Itoh, E. Yoshida, M. Miyagishi, A. Fukamizu, and M. Yamamoto, “Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription,” Genes to Cells, vol. 6, no. 10, pp. 857–868, 2001.View at: Google Scholar
N. Wakabayashi, A. T. Dinkova-Kostova, W. D. Holtzclaw et al., “Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers,” Proceedings of the National Academy of Sciences, vol. 101, no. 7, pp. 2040–2045, 2004.View at: Publisher Site | Google Scholar
M. G. Marini, I. Asunis, K. Chan et al., “Cloning MafF by recognition site screening with the NFE2 tandem repeat of HS2: analysis of its role in globin and GCSl genes regulation,” Blood Cells, Molecules, and Diseases, vol. 29, no. 2, pp. 145–158, 2002.View at: Google Scholar
Y. Wang, W. Devereux, T. M. Stewart, and R. A. Casero, “Characterization of the interaction between the transcription factors human polyamine modulated factor (PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the spermidine/spermine N1-acetyltransferase (SSAT) gene,” Biochemical Journal, vol. 355, no. 1, pp. 45–49, 2001.View at: Google Scholar
D. A. Bloom and A. K. Jaiswal, “Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression,” Journal of Biological Chemistry, vol. 278, no. 45, pp. 44675–44682, 2003.View at: Publisher Site | Google Scholar
D.-Y. Lee, C.-I. Lee, T.-E. Lin et al., “Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow,” Proceedings of the National Academy of Sciences, vol. 109, no. 6, pp. 1967–1972, 2012.View at: Publisher Site | Google Scholar
Y. Ikeda, A. Sugawara, Y. Taniyama et al., “Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor γ in macrophages via an interaction with NRF2,” Journal of Biological Chemistry, vol. 275, no. 42, pp. 33142–33150, 2000.View at: Publisher Site | Google Scholar
W. H. Organisation, Cardiovascular diseases (CVDs), 2017, http://www.who.int/mediacentre/factsheets/fs317/en/.
Y. Taniyama and K. K. Griendling, “Reactive oxygen species in the vasculature,” Molecular and Cellular Mechanisms, vol. 42, no. 6, pp. 1075–1081, 2003.View at: Google Scholar
N. Marui, M. K. Offermann, R. Swerlick et al., “Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells,” The Journal of Clinical Investigation, vol. 92, no. 4, pp. 1866–1874, 1993.View at: Publisher Site | Google Scholar
S. Chandra, M. J. Romero, A. Shatanawi, A. M. Alkilany, R. B. Caldwell, and R. W. Caldwell, “Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway,” British Journal of Pharmacology, vol. 165, no. 2, pp. 506–519, 2012.View at: Publisher Site | Google Scholar
M. J. Romero, D. H. Platt, H. E. Tawfik et al., “Diabetes-induced coronary vascular dysfunction involves increased arginase activity,” Circulation Research, vol. 102, no. 1, pp. 95–102, 2008.View at: Google Scholar
J. S. Chen, P. H. Huang, C. H. Wang et al., “Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract,” Atherosclerosis, vol. 214, no. 2, pp. 301–309, 2011.View at: Publisher Site | Google Scholar
X. Cheng, R. C. Siow, and G. E. Mann, “Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway,” Antioxidants & Redox Signaling, vol. 14, no. 3, pp. 469–487, 2011.View at: Publisher Site | Google Scholar
A. M. Mahmoud, F. L. Wilkinson, A. M. Jones et al., “A novel role for small molecule glycomimetics in the protection against lipid-induced endothelial dysfunction: involvement of Akt/eNOS and Nrf2/ARE signaling,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1861, no. 1, Part A, pp. 3311–3322, 2017.View at: Publisher Site | Google Scholar
H. L. Yang, M. Korivi, M. W. Lin, S. C. Chen, C. W. Chou, and Y. C. Hseu, “Anti-angiogenic properties of coenzyme Q0 through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling in TNF-α-activated human endothelial cells,” Biochemical Pharmacology, vol. 98, no. 1, pp. 144–156, 2015.View at: Publisher Site | Google Scholar
G. H. Dai, M. R. Kaazempur-Mofrad, S. Natarajan et al., “Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 41, pp. 14871–14876, 2004.View at: Google Scholar
J. J. Wentzel, Y. S. Chatzizisis, F. J. H. Gijsen, G. D. Giannoglou, C. L. Feldman, and P. H. Stone, “Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions,” Cardiovascular Research, vol. 96, no. 2, pp. 234–243, 2012.View at: Publisher Site | Google Scholar
K. Ishikawa, D. Sugawara, X.-p. Wang et al., “Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice,” Circulation Research, vol. 88, no. 5, pp. 506–512, 2001.View at: Google Scholar
B. Barajas, N. Che, F. Yin et al., “NF-E2–related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 58–66, 2011.View at: Publisher Site | Google Scholar
H.-J. Sim, J.-H. Kim, S.-H. Kook, S.-Y. Lee, and J.-C. Lee, “Glucose oxidase facilitates osteogenic differentiation and mineralization of embryonic stem cells through the activation of Nrf2 and ERK signal transduction pathways,” Molecular and Cellular Biochemistry, vol. 419, no. 1, pp. 157–163, 2016.View at: Publisher Site | Google Scholar
R. A. Lopes, K. B. Neves, R. C. Tostes, A. C. Montezano, and R. M. Touyz, “Downregulation of nuclear factor erythroid 2–related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension,” Hypertension, vol. 66, no. 6, pp. 1240–1250, 2015.View at: Publisher Site | Google Scholar
Y. Chen, J. T. Saari, and Y. J. Kang, “Weak antioxidant defenses make the heart a target for damage in copper-deficient rats,” Free Radical Biology and Medicine, vol. 17, no. 6, pp. 529–536, 1994.View at: Google Scholar
A. F. Amos, D. J. McCarty, and P. Zimmet, “The rising global burden of diabetes and its complications: estimates and projections to the year 2010,” Diabetic Medicine, vol. 14, Supplement 5, pp. S1–85, 1997.View at: Google Scholar
L. Cai and Y. J. Kang, “Oxidative stress and diabetic cardiomyopathy: a brief review,” Cardiovascular Toxicology, vol. 1, no. 3, pp. 181–193, 2001.View at: Google Scholar
L. Cai, Y. Wang, G. Zhou et al., “Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy,” Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1688–1697, 2006.View at: Publisher Site | Google Scholar
M. Hamblin, D. B. Friedman, S. Hill, R. M. Caprioli, H. M. Smith, and M. F. Hill, “Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 884–895, 2007.View at: Publisher Site | Google Scholar
T. Inoguchi, P. Li, F. Umeda et al., “High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells,” Diabetes, vol. 49, no. 11, pp. 1939–1945, 2000.View at: Google Scholar
H. Zhu, K. Itoh, M. Yamamoto, J. L. Zweier, and Y. Li, “Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury,” FEBS Letters, vol. 579, no. 14, pp. 3029–3036, 2005.View at: Publisher Site | Google Scholar
L. Cai, J. Wang, Y. Li et al., “Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy,” Diabetes, vol. 54, no. 6, pp. 1829–1837, 2005.View at: Google Scholar
Y. Wang, W. Sun, B. Du et al., “Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB,” The American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 4, pp. H567–H578, 2013.View at: Publisher Site | Google Scholar
L. Cai, “Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications,” Current Medicinal Chemistry, vol. 14, no. 20, pp. 2193–2203, 2007.View at: Google Scholar
D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956.View at: Google Scholar
R. Foncea, C. Carvajal, C. Almarza, and F. Leighton, “Endothelial cell oxidative stress and signal transduction,” Biological Research, vol. 33, no. 2, pp. 89–96, 2000.View at: Google Scholar
A. Manea, S. A. Manea, A. V. Gafencu, and M. Raicu, “Regulation of NADPH oxidase subunit p22phox by NF-kB in human aortic smooth muscle cells,” Archives of Physiology and Biochemistry, vol. 113, no. 4-5, pp. 163–172, 2007.View at: Google Scholar
A. J. Donato, I. Eskurza, A. E. Silver et al., “Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-κB,” Circulation Research, vol. 100, no. 11, pp. 1659–1666, 2007.View at: Publisher Site | Google Scholar
D. F. Goldspink, J. G. Burniston, and L. B. Tan, “Cardiomyocyte death and the ageing and failing heart,” Experimental Physiology, vol. 88, no. 3, pp. 447–458, 2003.View at: Google Scholar
S. Boudina, “Cardiac aging and insulin resistance: could insulin/insulin-like growth factor (IGF) signaling be used as a therapeutic target?” Current Pharmaceutical Design, vol. 19, no. 32, pp. 5684–5694, 2013.View at: Google Scholar
O. M. Duicu, S. N. Mirica, D. E. Gheorgheosu, A. I. Privistirescu, O. Fira-Mladinescu, and D. M. Muntean, “Ageing-induced decrease in cardiac mitochondrial function in healthy rats,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 8, pp. 593–600, 2013.View at: Publisher Site | Google Scholar
J. Kajstura, W. Cheng, R. Sarangarajan et al., “Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats,” The American Journal of Physiology, vol. 271, no. 3, Part 2, pp. H1215–H1228, 1996.View at: Google Scholar
M. N. Valcarcel-Ares, T. Gautam, J. P. Warrington et al., “Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 67, no. 8, pp. 821–829, 2012.View at: Publisher Site | Google Scholar
L. C. Bailey-Downs, M. Mitschelen, D. Sosnowska et al., “Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 67, no. 4, pp. 313–329, 2012.View at: Publisher Site | Google Scholar
Z. Ungvari, L. Bailey-Downs, D. Sosnowska et al., “Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2-mediated antioxidant response,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 301, no. 2, pp. H363–H372, 2011.View at: Publisher Site | Google Scholar
J. R. Stratton, W. C. Levy, M. D. Cerqueira, R. S. Schwartz, and I. B. Abrass, “Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men,” Circulation, vol. 89, no. 4, pp. 1648–1655, 1994.View at: Google Scholar
C. S. Huang, A. H. Lin, C. T. Liu et al., “Isothiocyanates protect against oxidized LDL-induced endothelial dysfunction by upregulating Nrf2-dependent antioxidation and suppressing NFκB activation,” Molecular Nutrition & Food Research, vol. 57, no. 11, pp. 1918–1930, 2013.View at: Publisher Site | Google Scholar
Y. Wang, Z. Zhang, W. Sun et al., “Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 123963, 11 pages, 2014.View at: Publisher Site | Google Scholar
D. R. Senger, M. V. Hoang, K. H. Kim, C. Li, and S. Cao, “Anti-inflammatory activity of Barleria lupulina: identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells,” Journal of Ethnopharmacology, vol. 193, pp. 397–407, 2016.View at: Publisher Site | Google Scholar
M. M. Sthijns, P. M. Schiffers, G. M. Janssen et al., “Rutin protects against H2O2-triggered impaired relaxation of placental arterioles and induces Nrf2-mediated adaptation in human umbilical vein endothelial cells exposed to oxidative stress,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1861, no. 5, Part A, pp. 1177–1189, 2017.View at: Publisher Site | Google Scholar
T. M. Teixeira, D. C. da Costa, A. C. Resende, C. O. Soulage, F. F. Bezerra, and J. B. Daleprane, “Activation of Nrf2-antioxidant signaling by 1,25-dihydroxycholecalciferol prevents leptin-induced oxidative stress and inflammation in human endothelial cells,” The Journal of Nutrition, vol. 147, no. 4, pp. 506–513, 2017.View at: Publisher Site | Google Scholar
A. Ishikado, Y. Sono, M. Matsumoto et al., “Willow bark extract increases antioxidant enzymes and reduces oxidative stress through activation of Nrf2 in vascular endothelial cells and Caenorhabditis elegans,” Free Radical Biology and Medicine, vol. 65, pp. 1506–1515, 2013.View at: Publisher Site | Google Scholar
K. Hiramatsu, T. Tsuneyoshi, T. Ogawa, and N. Morihara, “Aged garlic extract enhances heme oxygenase-1 and glutamate-cysteine ligase modifier subunit expression via the nuclear factor erythroid 2-related factor 2-antioxidant response element signaling pathway in human endothelial cells,” Nutrition Research, vol. 36, no. 2, pp. 143–149, 2016.View at: Publisher Site | Google Scholar
D. Fratantonio, F. Cimino, M. S. Molonia et al., “Cyanidin-3-O-glucoside ameliorates palmitate-induced insulin resistance by modulating IRS-1 phosphorylation and release of endothelial derived vasoactive factors,” Biochimica et Biophysica Acta, vol. 1862, no. 3, pp. 351–357, 2017.View at: Publisher Site | Google Scholar
D. Fratantonio, A. Speciale, D. Ferrari, M. Cristani, A. Saija, and F. Cimino, “Palmitate-induced endothelial dysfunction is attenuated by cyanidin-3-O-glucoside through modulation of Nrf2/Bach1 and NF-κB pathways,” Toxicology Letters, vol. 239, no. 3, pp. 152–160, 2015.View at: Publisher Site | Google Scholar
S. Sivasinprasasn, R. Pantan, S. Thummayot, J. Tocharus, A. Suksamrarn, and C. Tocharus, “Cyanidin-3-glucoside attenuates angiotensin II-induced oxidative stress and inflammation in vascular endothelial cells,” Chemico-Biological Interactions, vol. 260, pp. 67–74, 2016.View at: Publisher Site | Google Scholar
T. Zhang, Q. Hu, L. Shi, L. Qin, Q. Zhang, and M. Mi, “Equol attenuates atherosclerosis in apolipoprotein E-deficient mice by inhibiting endoplasmic reticulum stress via activation of Nrf2 in endothelial cells,” PLoS One, vol. 11, no. 12, article e0167020, 2016.View at: Publisher Site | Google Scholar
J. Fan, D. Liu, C. He, X. Li, and F. He, “Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38-VCAM-1 signal pathway,” Journal of Ethnopharmacology, vol. 192, pp. 423–430, 2016.View at: Publisher Site | Google Scholar
K. Onda, S. Tong, A. Nakahara et al., “Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia,” Hypertension, vol. 65, no. 4, pp. 855–862, 2015.View at: Publisher Site | Google Scholar
D. Fratantonio, A. Speciale, R. Canali et al., “Low nanomolar caffeic acid attenuates high glucose-induced endothelial dysfunction in primary human umbilical-vein endothelial cells by affecting NF-κB and Nrf2 pathways,” BioFactors, vol. 43, no. 1, pp. 54–62, 2017.View at: Publisher Site | Google Scholar
H. C. Lin, S. L. Su, C. Y. Lu et al., “Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells,” Environmental Toxicology, vol. 32, no. 3, pp. 918–930, 2017.View at: Publisher Site | Google Scholar
S. Zhuang, T. H. Cheng, N. L. Shih et al., “Tanshinone IIA induces heme oxygenase 1 expression and inhibits cyclic strain-induced interleukin 8 expression in vascular endothelial cells,” The American Journal of Chinese Medicine, vol. 44, no. 2, pp. 377–388, 2016.View at: Publisher Site | Google Scholar
L. C. Sung, H. H. Chao, C. H. Chen et al., “Lycopene inhibits cyclic strain-induced endothelin-1 expression through the suppression of reactive oxygen species generation and induction of heme oxygenase-1 in human umbilical vein endothelial cells,” Clinical and Experimental Pharmacology & Physiology, vol. 42, no. 6, pp. 632–639, 2015.View at: Publisher Site | Google Scholar
H. C. Chang, H. L. Yang, J. H. Pan et al., “Hericium erinaceus inhibits TNF-α-induced angiogenesis and ROS generation through suppression of MMP-9/NF-κB signaling and activation of Nrf2-mediated antioxidant genes in human EA.hy926 endothelial cells,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 8257238, 15 pages, 2016.View at: Publisher Site | Google Scholar
T. L. Yen, R. J. Chen, T. Jayakumar et al., “Andrographolide stimulates p38 mitogen-activated protein kinase-nuclear factor erythroid-2-related factor 2-heme oxygenase 1 signaling in primary cerebral endothelial cells for definite protection against ischemic stroke in rats,” Translational Research, vol. 170, pp. 57–72, 2016.View at: Publisher Site | Google Scholar
W. Sun, X. Wang, C. Hou et al., “Oleuropein improves mitochondrial function to attenuate oxidative stress by activating the Nrf2 pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats,” Neuropharmacology, vol. 113, Part A, pp. 556–566, 2017.View at: Publisher Site | Google Scholar
Z. Zhang, J. Chen, S. Zhou et al., “Magnolia bioactive constituent 4-O-methylhonokiol prevents the impairment of cardiac insulin signaling and the cardiac pathogenesis in high-fat diet-induced obese mice,” International Journal of Biological Sciences, vol. 11, no. 8, pp. 879–891, 2015.View at: Publisher Site | Google Scholar
X. Zheng, S. Zhu, S. Chang et al., “Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling,” European Journal of Pharmacology, vol. 720, no. 1, pp. 147–157, 2013.View at: Publisher Site | Google Scholar
Y. Wang, W. Sun, B. Du et al., “Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 4, pp. H567–H578, 2013.View at: Publisher Site | Google Scholar